C4 Therapeutics (CCCC) PT Lowered to $5 at Morgan Stanley
Tweet
Share
E-mailGet Alerts CCCC Hot Sheet
Price: $4.24 +3.92%
Rating Summary:
10 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
10 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Morgan Stanley analyst Terence Flynn lowered the price target on C4 Therapeutics (NASDAQ: CCCC) to $5.00 (from $6.00) while maintaining a Underweight rating.
You May Also Be Interested In
- C4 Therapeutics, Inc. (CCCC) Tops Q2 EPS by 3c
- Travel Food Services (TRAVELFO:IN) PT Raised to INR1,600 at ICICI Securities
- KP Tissue Inc. (KPT:CN) (KPTSF) PT Raised to Cdn$13.50 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
